Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

InheRET: A SaaS solution to identifying patients at increased risk for hereditary disease

Award Number: R41CA239842
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2019
PERIOD OF PERFORMANCE END DATE: 09/09/2020

Group Awards By:

View Award Description

InheRET: A SaaS solution to identifying patients at increased risk for hereditary disease - Project Summary This project is to complete the development, integration with the electronic medical record and human testing of the InheRET Inherited Risk Evaluation Tool. InheRET’s aim is to quickly and easily identify individuals at increased risk for hereditary diseases, thereby facilitating their to access downstream risk-appropriate care, reducing morbidity and mortality. InheRET’s unique features reduces clinical ascertainment barriers by gathering a patient provided family history, produces a report based on patient and family history that streamlines workflows and enhances patient outcomes and cost effectiveness within health systems. The aims for this project are to complete in silico (computer generated) testing of the algorithms driving the InheRET data analytics for the case of cancer risk, followed by pilot testing in a variety of clinical settings to determine if further refinements are needed to the product, prior to commercialization. As part of this STTR project, we will integrate the InheRET program with an EPIC electronic health record system to seamlessly communicate InheRET reports within the patient medical records, to be accessible to both patient and practitioner. Success will be determined if we achieve 100% concordance with the in silico testing (i.e. concluding that all algorithms function correctly), 98% concordance with clinical determinations in the clinical pilot testing, and 100% concordance in the integration testing (all patient reports are appropriately routed to the proper medical records). Our primary objective is to produce an accurate, easy-to-use and understandable report to ensure individuals who may unknowingly harbor inherited genetic mutations are identified, thereby enabling them to access genetic counselors and testing along with appropriate downstream care. By doing so, patients can reduce their risk of disease, receive tailored treatment if they incur disease, and reduce overall mortality. Moreover, InheRET will cut costs by assisting in focusing resources on those whose risk warrants enhanced measures. Conversely, by reducing incidence of hereditary cancers or the advanced presentation of cancers or other hereditary chronic illnesses, a multitude of costs associated with complex treatments can likewise be reduced, while increasing quality and length of life.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2022 ( Subtotal = $360 )
2022	2019	INHERET, INC	3470 GREENLEAF CT	ANN ARBOR	MI	48105	WASHTENAW	USA	Cancer Cause and Prevention Research	000	1	9/26/2022	NEW	$360
														Subtotal = $360

Issue Date FY: 2021 ( Subtotal = -$20,456 )
2021	2019	INHERET, INC	1600 HURON PKWY BLDG 520-2341	ANN ARBOR	MI	48109	WASHTENAW	USA	Cancer Cause and Prevention Research	000	1	2/1/2021	NEW	$0
2021	2019	INHERET, INC	3470 GREENLEAF CT	ANN ARBOR	MI	48105	WASHTENAW	USA	Cancer Cause and Prevention Research	001	1	4/23/2021	NEW	-$20,456
														Subtotal = -$20,456

Issue Date FY: 2019 ( Subtotal = $299,828 )
2019	2019	INHERET, INC	3470 GREENLEAF CT	ANN ARBOR	MI	48105	WASHTENAW	USA	Cancer Cause and Prevention Research	000	1	3/22/2019	NEW	$299,828
														Subtotal = $299,828

Grand Total All Awards = $279,732

Top

All Categories

About

Search

Reports

Data Submission

Award Information

InheRET: A SaaS solution to identifying patients at increased risk for hereditary disease

Award Number: R41CA239842

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2019

PERIOD OF PERFORMANCE END DATE: 09/09/2020

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer